NovoCureNVCR

那斯達克 · USD
12.71
-0.33
(-2.53%)
盤中 03/10 02:08 (UTC+8)
03/10 02:08 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.27
  • 1.34
  • 1.39
  • 1.50
  • 1.55
  • 1.61
  • 1.55
  • 1.59
  • 1.67
  • 1.74
icon
  • 1.01
  • 5.08
  • 3.53
  • 8.56
  • 3.15
  • 3.98
  • -3.89
  • 2.46
  • 5.29
  • 4.27
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
174,350
167,204
158,805
154,994
161,266
155,095
150,356
138,503
133,784
127,321
營業成本
42,15744,72941,47238,52133,46635,37234,65433,68932,55632,092
營業毛利
132,193
122,475
117,333
116,473
127,800
119,723
115,702
104,814
101,228
95,229
營業費用
172,586158,496156,854154,338191,104151,815149,282146,334152,944153,474
研發費用
60,90554,02955,83353,77751,21051,88254,95551,59854,30853,623
推銷及管理費用
111,681104,467101,021100,561139,89499,93394,32794,73698,63699,851
非經常性項目費用
----------
其他營業費用
----------
營業利益
-40,393
-36,021
-39,521
-37,865
-63,304
-32,092
-33,580
-41,520
-51,716
-58,245
其他收入及費用
----------
利息費用
----------
稅前純益
-40,954
-30,022
-34,979
-30,295
-55,206
-21,585
-22,729
-31,642
-38,534
-48,222
所得稅
-16,4557,2485,1604,02410,7168,98510,6467,1188,5451,263
稅後純益
-24,499
-37,270
-40,139
-34,319
-65,922
-30,570
-33,375
-38,760
-47,079
-49,485
基本每股稅後盈餘(元)
-0.22-0.33-0.36-0.31-0.61-0.28-0.31-0.36-0.45-0.46
稀釋每股稅後盈餘(元)
-0.22-0.33-0.36-0.31-0.61-0.28-0.31-0.36-0.44-0.47
基本平均股數(千股)
112126.00111908.00111572.00110281.00108474.00108247.00107700.00107266.00106983.00106772.00
稀釋平均股數(千股)
112126.00111908.00111572.00110281.00108474.00108247.00107700.00107266.00106983.00106772.00
還原基本每股稅後盈餘(元)
-0.22-0.33-0.36-0.31-0.61-0.28-0.31-0.36-0.45-0.46
還原稀釋每股稅後盈餘(元)
-0.22-0.33-0.36-0.31-0.61-0.28-0.31-0.36-0.44-0.47
還原基本平均股數(千股)
112,126111,908111,572110,281108,474108,247107,700107,266106,983106,772
還原稀釋平均股數(千股)
112,126111,908111,572110,281108,474108,247107,700107,266106,983106,772
EBITDA(千元)
-40,482-32,761-37,995-33,624-58,774-25,864-26,725-34,208-43,073-52,110

大家都在看

HOT